Exclusive

Publication

Byline

Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More


Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More


Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More


Singapore Clinical Trial: CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib Plus Pembrolizumab Versus Pembrolizumab And Pemetrexed And Carboplatin or Cisplatin in Patients with Previously Untreated, KRAS G12C-Mutated, Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... Read More


Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... Read More


Two Thar SUVs Seized in Goa Over Illegal Tourist Taxi Operations; Driver Accused of Hitting Woman

Goa, June 2 -- Vehicles allegedly operating commercially with white number plates handed over to Traffic Police by Rent-a-Cab Association members. Two Mahindra Thar vehicles allegedly being used for ... Read More


What is the forged signature scandal rocking TMC, Mamata Banerjee after Bengal poll defeat?

India, June 2 -- The Trinamool Congress (TMC) is facing one of its most serious internal crises after allegations that signatures of several party legislators were forged on official documents submitt... Read More


INR 200 crore from an INR 40 crore team: Sooryavanshi, Patidar and IPL 2026's bargain XI turn auction logic upside down

India, June 2 -- Every IPL franchise had Rs.120 crore to build a squad. That purse was meant to buy everything: openers, finishers, wicketkeepers, Indian pace, overseas power, spin cover, all-round de... Read More


Delhi athletes test preparations for Inter-State championships

India, June 2 -- The three-day Delhi State Open Athletics Championship is an opportunity for athletes to test their preparation for the National Inter-State Championships where the team for the Asian ... Read More


KCET result date and time: Karnataka CET results expected soon at karresults.nic.in; how to check?

New Delhi, June 2 -- The Karnataka Examinations Authority or KEA may soon announce the result of the Undergraduate Common Entrance Test (UGCET or KCET 2026). Candidates who have appeared for the exami... Read More